Rafael Amado - Jul 5, 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
EVP of R&D and CMO
Signature
Veer Bhavnagri as attorney-in-fact for Rafael Amado
Stock symbol
ALLO
Transactions as of
Jul 5, 2022
Transactions value $
-$22,880
Form type
4
Date filed
7/6/2022, 04:16 PM
Previous filing
Jun 22, 2022
Next filing
Aug 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Sale -$22.9K -2K -0.37% $11.44 542K Jul 5, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022.